GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zeria Pharmaceutical Co Ltd (TSE:4559) » Definitions » Cyclically Adjusted PS Ratio

Zeria Pharmaceutical Co (TSE:4559) Cyclically Adjusted PS Ratio : 1.44 (As of Jun. 01, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Zeria Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-01), Zeria Pharmaceutical Co's current share price is 円1987.00. Zeria Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円1,380.19. Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 1.44.

The historical rank and industry rank for Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4559' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.23   Med: 1.64   Max: 2.08
Current: 1.41

During the past years, Zeria Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 2.08. The lowest was 1.23. And the median was 1.64.

TSE:4559's Cyclically Adjusted PS Ratio is ranked better than
64.65% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.085 vs TSE:4559: 1.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zeria Pharmaceutical Co's adjusted revenue per share data for the three months ended in Dec. 2023 was 円481.869. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円1,380.19 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zeria Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zeria Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Zeria Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.67 1.69 1.51 1.68 -

Zeria Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.81 1.63 1.46 -

Competitive Comparison of Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Zeria Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1987.00/1380.19
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeria Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Zeria Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=481.869/106.8000*106.8000
=481.869

Current CPI (Dec. 2023) = 106.8000.

Zeria Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 287.350 95.700 320.679
201406 277.273 98.000 302.171
201409 290.160 98.500 314.610
201412 294.165 97.900 320.907
201503 287.979 97.900 314.159
201506 277.292 98.400 300.963
201509 293.927 98.500 318.694
201512 314.381 98.100 342.262
201603 290.681 97.900 317.107
201606 310.424 98.100 337.954
201609 297.867 98.000 324.614
201612 314.642 98.400 341.502
201703 298.195 98.100 324.640
201706 300.826 98.500 326.175
201709 319.164 98.800 345.007
201712 338.814 99.400 364.038
201803 295.362 99.200 317.991
201806 303.125 99.200 326.348
201809 303.577 99.900 324.545
201812 336.647 99.700 360.621
201903 301.659 99.700 323.141
201906 318.200 99.800 340.519
201909 326.578 100.100 348.437
201912 344.217 100.500 365.795
202003 304.821 100.300 324.575
202006 275.221 99.900 294.230
202009 277.121 99.900 296.261
202012 322.000 99.300 346.320
202103 270.687 99.900 289.383
202106 297.231 99.500 319.038
202109 333.589 100.100 355.917
202112 365.993 100.100 390.490
202203 322.371 101.100 340.546
202206 367.971 101.800 386.044
202209 394.294 103.100 408.444
202212 408.147 104.100 418.733
202303 377.707 104.400 386.390
202306 415.257 105.200 421.573
202309 416.830 106.200 419.185
202312 481.869 106.800 481.869

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zeria Pharmaceutical Co  (TSE:4559) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Zeria Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Zeria Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zeria Pharmaceutical Co (TSE:4559) Business Description

Traded in Other Exchanges
N/A
Address
10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.

Zeria Pharmaceutical Co (TSE:4559) Headlines

No Headlines